Twist Bioscience Corp financial data

Symbol
TWST on Nasdaq
Location
South San Francisco, CA
Fiscal year end
September 30
Latest financial report
10-K - Q3 2025 - Nov 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 420 % -20.8%
Quick Ratio 30.5 % -25.6%
Debt-to-equity 34.8 % +28.1%
Return On Equity -16.8 % +57.4%
Return On Assets -12.5 % +59.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61.1M shares +3.02%
Common Stock, Shares, Outstanding 60.6M shares +2.98%
Entity Public Float 2.32B USD +20.8%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 59.8M shares +3.09%
Weighted Average Number of Shares Outstanding, Diluted 59.8M shares +3.09%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 186M USD +3.31%
Research and Development Expense 80.3M USD -11.6%
Costs and Expenses 513M USD -3.93%
Operating Income (Loss) -136M USD +38.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -77M USD +63%
Income Tax Expense (Benefit) 719K USD +28.4%
Net Income (Loss) Attributable to Parent -77.7M USD +62.8%
Earnings Per Share, Basic -1 USD/shares +63.9%
Earnings Per Share, Diluted -1 USD/shares +63.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 183M USD -19.1%
Cash, Cash Equivalents, and Short-term Investments 289M USD -19.8%
Accounts Receivable, after Allowance for Credit Loss, Current 57M USD +63.4%
Inventory, Net 28.3M USD +17.6%
Assets, Current 333M USD -3.98%
Property, Plant and Equipment, Net 102M USD -0.23%
Operating Lease, Right-of-Use Asset 49.4M USD -16.1%
Goodwill 82.2M USD -4.21%
Other Assets, Noncurrent 4.9M USD +213%
Assets 642M USD +4.48%
Accounts Payable, Current 11.1M USD +581%
Employee-related Liabilities, Current 31.3M USD -7.02%
Accrued Liabilities, Current 23.1M USD +52.6%
Liabilities, Current 91.4M USD +28.7%
Operating Lease, Liability, Noncurrent 61.8M USD -12.1%
Other Liabilities, Noncurrent 747K USD +83.5%
Liabilities 169M USD +19.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -627K USD -20.1%
Retained Earnings (Accumulated Deficit) -1.32B USD -6.25%
Stockholders' Equity Attributable to Parent 473M USD +0.06%
Liabilities and Equity 642M USD +4.48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.4M USD +6.73%
Net Cash Provided by (Used in) Financing Activities 17.9M USD
Net Cash Provided by (Used in) Investing Activities -1.54M USD -137%
Common Stock, Shares Authorized 200M shares +100%
Common Stock, Shares, Issued 60.6M shares +2.98%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.07M USD +74.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 185M USD -19.1%
Deferred Tax Assets, Valuation Allowance 383M USD +6.32%
Deferred Tax Assets, Gross 399M USD +5.27%
Operating Lease, Liability 75.6M USD -11.1%
Depreciation 23.8M USD -12.8%
Payments to Acquire Property, Plant, and Equipment 2.27M USD +50.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -77.8M USD +62.7%
Lessee, Operating Lease, Liability, to be Paid 119M USD -10.9%
Property, Plant and Equipment, Gross 197M USD +10.7%
Operating Lease, Liability, Current 13.8M USD -6.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.45M USD -39.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 14M USD -5.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 43.4M USD -10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.51M USD +1.66%
Deferred Tax Assets, Operating Loss Carryforwards 232M USD +2.39%
Unrecognized Tax Benefits 25.3M USD +12.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.61M USD -22%
Operating Lease, Payments 14.7M USD +0.02%
Additional Paid in Capital 1.79B USD +4.55%
Amortization of Intangible Assets 1.1M USD -73.2%
Depreciation, Depletion and Amortization 6.38M USD -21.9%
Deferred Tax Assets, Net of Valuation Allowance 15.4M USD -15.5%
Share-based Payment Arrangement, Expense 64.5M USD +26.6%
Interest Expense 2K USD -92.9%